Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Explore the inspiring stories of the Fierce 50
Boehringer Ingelheim
Pharma
Boehringer rolls out unbranded Humira biosim at steep discount
Boehringer Ingelheim, which launched the first interchangeable biosimilar to AbbVie’s Humira, is getting in on the industry’s double-pricing trick.
Fraiser Kansteiner
Oct 4, 2023 10:53am
Boehringer joins the list of drugmakers suing over the IRA
Aug 22, 2023 8:01pm
Boehringer posts more Jardiance growth as CKD launch nears
Aug 1, 2023 1:35pm
Lilly, BI's Jardiance scores EU nod in chronic kidney disease
Jul 26, 2023 11:39am
AbbVie's Skyrizi tops Amgen's Otezla in head-to-head study
Jul 26, 2023 10:45am
Respiratory patient groups decry pricing, access to lung meds
Jul 24, 2023 7:34am
